# US 2009/0269831 A1 · Modified cytosine deaminases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0269831 A1
- Document ID: US20090269831A1
- Status: Published application
- Kind: A1
- Application number: 12/322,868
- Filed: 2009-02-06
- Published: 2009-10-29
- Earliest claimed: 2008-02-07
- Assignees: Regents of the University of Minnesota
- Inventors: Reuben S. Harris; Hiroshi Matsuo
- Web page: https://patentgrep.com/patent/US20090269831A1

## CPC

- C12N 9/78: acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12Y 305/04005: Cytidine deaminase (3.5.4.5)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The document provides modified cytosine deaminases with increased solubility and high levels of DNA cytosine deaminase activity.

## Claims

### Claim 1

An isolated polypeptide comprising a cytosine deaminase amino acid sequence that aligns with the amino acid sequence set forth in SEQ ID NO:2, wherein said cytosine deaminase amino acid sequence comprises (a) an amino acid other than leucine at the position aligning with position 234 of said amino acid sequence or (b) an amino acid other than phenylalanine at the position aligning with position 310 of said amino acid sequence.

### Claim 2 (depends on 1)

The polypeptide of claim 1, wherein said cytosine deaminase amino acid sequence comprises (a) an amino acid other than leucine at the position aligning with position 234 of said amino acid sequence and (b) an amino acid other than phenylalanine at the position aligning with position 310 of said amino acid sequence.

### Claim 3 (depends on 1)

The polypeptide of claim 1, wherein said cytosine deaminase polypeptide amino acid sequence comprises an alanine or a lysine at the position aligning with position 234 of said amino acid sequence.

### Claim 4 (depends on 1)

The polypeptide of claim 1, wherein said cytosine deaminase polypeptide amino acid sequence comprises an alanine, serine, or a lysine at the position aligning with position 310 of said amino acid sequence.

### Claim 5 (depends on 1)

The polypeptide of claim 1, wherein said cytosine deaminase polypeptide amino acid sequence comprises (a) an alanine or a lysine at the position aligning with position 234 of said amino acid sequence and (b) an alanine, serine, or a lysine at the position aligning with position 310 of said amino acid sequence.

### Claim 6 (depends on 1)

The polypeptide of claim 1, wherein said cytosine deaminase amino acid sequence lacks the amino acid residues aligning with residues 1 to 174 of said sequence, lacks the amino acid sequences aligning with residues 1 to 190 of said sequence, or lacks the amino acid sequences aligning with residues 1 to 197 of said sequence.

### Claim 7 (depends on 6)

The polypeptide of claim 6, wherein said cytosine deaminase polypeptide amino acid sequence comprises (a) an alanine or lysine at the position aligning with position 234 of said amino acid sequence and (b) an alanine, serine, or a lysine at the position aligning with position 310 of said amino acid sequence.

### Claim 8 (depends on 1)

The polypeptide of claim 1, wherein said cytosine deaminase amino acid sequence further comprises (c) an amino acid other than cysteine at the position aligning with position 243 of said amino acid sequence, (d) an amino acid other than cysteine at the position aligning with position 321 of said amino acid sequence, or (e) an amino acid other than cysteine at the position aligning with position 356 of said amino acid sequence.

### Claim 9 (depends on 7)

The polypeptide of claim 7, wherein said cytosine deaminase amino acid sequence further comprises (c) an amino acid other than cysteine at the position aligning with position 243 of said amino acid sequence, (d) an amino acid other than cysteine at the position aligning with position 321 of said amino acid sequence, and (e) an amino acid other than cysteine at the position aligning with position 356 of said amino acid sequence.

### Claim 10 (depends on 8)

The polypeptide of claim 8, wherein said cytosine deaminase amino acid sequence comprises (c) an alanine or glycine at the position aligning with position 243 of said amino acid sequence, (d) an alanine at the position aligning with position 321 of said amino acid sequence, and (e) an alanine at the position aligning with position 356 of said amino acid sequence.

### Claim 11 (depends on 9)

The polypeptide of claim 9, wherein said cytosine deaminase amino acid sequence comprises (c) an alanine or glycine at the position aligning with position 243 of said amino acid sequence, (d) an alanine at the position aligning with position 321 of said amino acid sequence, and (e) an alanine at the position aligning with position 356 of said amino acid sequence.

### Claim 12

A purified mutant cytosine deaminase polypeptide, wherein said mutant cytosine deaminase polypeptide is catalytically active and has enhanced solubility relative to a corresponding cytosine deaminase.

### Claim 13 (depends on 12)

The polypeptide of claim 12, wherein said corresponding cytosine deaminase has the amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6.

### Claim 14 (depends on 13)

The polypeptide of claim 13, wherein said mutant cytosine deaminase polypeptide comprises an amino acid sequence that aligns with the amino acid sequence set forth in SEQ ID NO:2, and wherein said mutant cytosine deaminase amino acid sequence comprises (a) an amino acid other than leucine at the position aligning with position 234 of said amino acid sequence, (b) an amino acid other than leucine at the position aligning with position 235 of said amino acid sequence, (c) an amino acid other than phenylalanine at the position aligning with position 241 of said amino acid sequence, (d) an amino acid other than leucine at the position aligning with position 253 of said amino acid sequence, (e) an amino acid other than phenylalanine at the position aligning with position 310 of said amino acid sequence, or (f) an amino acid other than leucine at the position aligning with position 371 of said amino acid sequence.

### Claim 15 (depends on 14)

The polypeptide of claim 14, wherein said mutant cytosine deaminase amino acid sequence comprises (a) an alanine or a lysine at the position aligning with position 234 of said amino acid sequence, (b) an alanine at the position aligning with position 235 of said amino acid sequence, (c) an alanine at the position aligning with position 241 of said amino acid sequence, (d) an alanine or lysine at the position aligning with position 253 of said amino acid sequence, (e) an alanine, serine, or lysine at the position aligning with position 310 of said amino acid sequence, or (f) an alanine at the position aligning with position 371 of said amino acid sequence.

### Claim 16 (depends on 15)

The polypeptide of claim 15, wherein said mutant cytosine deaminase amino acid sequence lacks the amino acid residues aligning with residues 1 to 174 of SEQ ID NO:2, lacks the amino acid sequences aligning with residues 1 to 190 of SEQ ID NO:2, or lacks the amino acid sequences aligning with residues 1 to 197 of SEQ ID NO:2.

### Claim 17 (depends on 13)

The polypeptide of claim 13, wherein said mutant cytosine deaminase amino acid sequence lacks the amino acid sequences aligning with residues 1 to 184 of SEQ ID NO:4; or lacks the amino acid sequences aligning with residues 188 to 198 of SEQ ID NO:6.

### Claim 18 (depends on 13)

The polypeptide of claim 13, wherein said mutant cytosine deaminase amino acid sequence comprises (a) a lysine at the position aligning with position 44 of SEQ ID NO:6 and (b) a lysine at the position aligning with position 109 of SEQ ID NO:6.

### Claim 19 (depends on 17)

The polypeptide of claim 17, wherein said mutant cytosine deaminase amino acid sequence comprises (a) a lysine at the position aligning with position 44 of SEQ ID NO:6 and (b) a lysine at the position aligning with position 109 of SEQ ID NO:6.

### Claim 20 (depends on 13)

The polypeptide of claim 13, wherein said mutant cytosine deaminase amino acid sequence comprises (a) a lysine, aspartic acid, or glutamic acid residue at the position aligning with position 302 of SEQ ID NO:4, (b) an alanine residue at the position aligning with position 314 of SEQ ID NO:4, or (c) an alanine residue at the position aligning with position 315 of SEQ ID NO:4.

### Claim 21 (depends on 20)

The polypeptide of claim 20, wherein said mutant cytosine deaminase amino acid sequence comprises (a) a lysine, aspartic acid, or glutamic acid residue at the position aligning with position 302 of SEQ ID NO:4, (b) an alanine residue at the position aligning with position 314 of SEQ ID NO:4, and (c) an alanine residue at the position aligning with position 315 of SEQ ID NO:4.

### Claim 22 (depends on 17)

The polypeptide of claim 17, wherein said mutant cytosine deaminase amino acid sequence comprises (a) a lysine, aspartic acid, or glutamic acid residue at the position aligning with position 302 of SEQ ID NO:4, (b) an alanine residue at the position aligning with position 314 of SEQ ID NO:4, or (c) an alanine residue at the position aligning with position 315 of SEQ ID NO:4.

### Claim 23 (depends on 22)

The polypeptide of claim 22, wherein said mutant cytosine deaminase amino acid sequence comprises (a) a lysine, aspartic acid, or glutamic acid residue at the position aligning with position 302 of SEQ ID NO:4, (b) an alanine residue at the position aligning with position 314 of SEQ ID NO:4, and (c) an alanine residue at the position aligning with position 315 of SEQ ID NO:4

### Claim 24

An isolated nucleic acid encoding a mutant cytosine deaminase polypeptide, wherein said mutant cytosine deaminase polypeptide is catalytically active and has enhanced solubility relative to a corresponding cytosine deaminase having the amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6.

### Claim 25

A kit comprising a mutant cytosine deaminase polypeptide, wherein said mutant cytosine deaminase polypeptide is catalytically active and has enhanced solubility relative to a cytosine deaminase having the amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6.

### Claim 26 (depends on 25)

The kit of claim 25, wherein said kit further comprises a reagent selected from the group consisting of an antibody, a buffer, a uracil DNA glycosylase, or a nucleic acid.
